Vitality Watch

Dossier clinicaltrials trial early 12-aug-2026
Small or early-phase human trial or pilot study

The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults

Key claim: The Mito-Frail trial is testing whether MitoQ supplementation can improve central and cerebral vascular function, reduce oxidative stress, and enhance mobility and cognitive performance in frail older adults.

Abstract

The goal of this clinical trial is to test the effects of MitoQ supplementation in older adults and frail older adults with physical dysfunction and/or cognitive dysfunction. The main question[s] it aims to answer are:

  • To compare vascular function, oxidative stress levels, and physical and cognitive function among older adults and frail older adults with physical and cognitive dysfunction
  • To determine whether MitoQ supplementation has the potential to improve vascular function in central and cerebral vessels
  • To determine whether MitoQ supplementation can enhance physical and cognitive capabilities.

Why this matters

Mito-Frail is one of the few registered human trials directly testing a mitochondria-targeted antioxidant (MitoQ) against frailty-relevant vascular, mobility, and cognitive endpoints, rather than surrogate biomarkers in healthy volunteers. Because prior MitoQ human work has been dominated by short vascular-function studies in healthier adults, a frailty-population readout would be an unusually direct test of whether the mitochondrial-ROS-to-endothelial-dysfunction chain translates to a clinically vulnerable group. Until results publish, this remains a protocol-stage signal — the mechanistic pitch outruns the outcome data.

Source

Link

Briefing card

The Mito-Frail Trial: Effects of MitoQ on Vasodilation, Mobility and Cognitive Performance in Frail Older Adults
Stage: trial early · clinicaltrials · 12-aug-2026

The Mito-Frail trial is testing whether MitoQ supplementation can improve central and cerebral vascular function, reduce oxidative stress, and enhance mobility and cognitive performance in frail older adults.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT06027554

build build 880 · 2bcef25 · 2026-11-18